Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
IntraBio's Aqneursa scores FDA approval for rare ataxia
Aqneursa is now the first treatment indicated for a rare and prematurely fatal ataxia.
Donavyn Coffey
Sep 21, 2026 11:10am
Novo struggles to appease restless investors with new strategy
Sep 21, 2026 10:50am
Clinical trials reach a new automation inflection point
Brought to you by
IQVIA
Bayer sells cancer drug Stivarga to Grünenthal for up to $431M
Sep 21, 2026 10:20am
How is API Manufacturing Changing?
Brought to you by
WuXi AppTec
Newly uncovered MFN drug pricing details reignite concerns
Sep 21, 2026 12:02am
